SKI Market

Indian Indices

Nifty

24,971.90 -140.50
(-0.56%)

Sensex

81,896.79 -511.38
( -0.62%)

Bank Nifty

56,059.35 -193.50
( -0.34%)

Nifty IT

38,414.10 -577.35
( -1.48%)

Global Indices

Nasdaq

42,233.20 40.53
(0.10%)

Dow Jones

5,989.55 -12.32
(-0.21%)

Hang Seng

38,330.35 -72.88
(-0.19%)

Nikkei 225

8,774.65 -17.15
(-0.20%)

Forex

USD-INR

86.67 0.24
(0.27%)

EUR-INR

99.45 0.06
(0.06%)

GBP-INR

116.39 0.20
(0.17%)

JPY-INR

0.60 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Beta Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535022

INE351Y01019

127.8259206

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BETA

95.48

1790.77

EPS(TTM)

Face Value()

Div & Yield %

18.58

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	197.62	157.87	124.85	79.46	65.32	58.05
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	197.62	157.87	124.85	79.46	65.32	58.05
Other Income	1.73	1.04	0.86	0.61	0.42	0.32
Stock Adjustments	6.98	3.17	-0.86	1.38	-0.20	2.67
Total Income	206.33	162.08	124.85	81.45	65.54	61.04
EXPENDITURE :
Raw Materials	119.27	86.47	69.86	44.83	34.61	33.28
Power & Fuel Cost	3.83	3.06	2.28	1.84	1.46	1.05
Employee Cost	11.08	10.31	6.70	4.53	3.70	2.45
Other Manufacturing Expenses	13.53	12.51	10.04	7.65	6.64	6.52
Selling & Administrative Expenses	22.74	17.08	9.61	6.23	6.59	6.39
Miscellaneous Expenses	0.62	0.42	0.31	0.45	0.37	0.73
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	171.07	129.85	98.80	65.53	53.36	50.42
Operating Profit	35.26	32.24	26.04	15.92	12.17	10.62
Interest	1.05	0.84	0.41	0.77	0.64	0.73
Gross Profit	34.21	31.40	25.63	15.15	11.53	9.89
Depreciation	4.72	6.19	5.47	5.27	2.58	2.42
Profit Before Tax	29.49	25.21	20.16	9.88	8.95	7.47
Tax	7.47	6.68	6.15	3.30	1.72	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.08	-0.29	-0.24	-0.40	0.13	-0.25
Reported Net Profit	21.94	18.82	14.25	6.98	7.10	7.71
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	21.94	18.82	14.25	6.98	7.10	7.71
Adjustment below Net Profit	-2.18	-0.02	-0.20	0.00	0.00	0.00
P & L Balance brought forward	62.70	43.91	29.86	22.89	15.79	8.07
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	82.46	62.70	43.91	29.86	22.89	15.79
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	22.82	19.57	14.82	7.26	7.39	8.92
Earnings Per Share(Adj)-Unit Curr	22.82	18.64	14.82	6.91	7.04	8.49
Book Value-Unit Curr	120.67	100.12	80.57	65.96	58.71	46.93
Book Value(Adj)-Unit Curr	120.67	95.35	80.57	62.82	55.92	44.69

24,971.90 -140.50 (-0.56%)

81,896.79 -511.38 ( -0.62%)

56,059.35 -193.50 ( -0.34%)

38,414.10 -577.35 ( -1.48%)

42,233.20 40.53 (0.10%)

5,989.55 -12.32 (-0.21%)

38,330.35 -72.88 (-0.19%)

8,774.65 -17.15 (-0.20%)

86.67 0.24 (0.27%)

99.45 0.06 (0.06%)

116.39 0.20 (0.17%)

0.60 0.00 (-0.02%)